Detrol and Bone marrow failure - a phase IV clinical study of FDA data

Summary:

Bone marrow failure is reported as a side effect among people who take Detrol (tolterodine tartrate), especially for people who are male, 60+ old, also take Compazine, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Bone marrow failure when taking Detrol. It is created by eHealthMe based on reports of 28,229 people who have side effects when taking Detrol from the FDA, and is updated regularly.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

What is Bone marrow failure?

Bone marrow failure is found to be associated with 1,008 drugs and 1,438 conditions by eHealthMe. Check the latest studies of Bone marrow failure.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

28,229 people reported to have side effects when taking Detrol.
Among them, 12 people (0.04%) have Bone marrow failure.

Among these 12 people:

What is the gender of people who have Bone marrow failure when taking Detrol? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Bone marrow failure when taking Detrol? *

What are other drugs people take besides Detrol? *

What are other side effects people have besides Bone marrow failure? *

Acute Respiratory Failure: 6 people, 50.00%
Hypotension (abnormally low blood pressure): 6 people, 50.00%
Pneumonia: 6 people, 50.00%
Confusional State: 5 people, 41.67%
Lung Infection: 5 people, 41.67%
Back Pain: 3 people, 25.00%
Activated Partial Thromboplastin Time Prolonged: 2 people, 16.67%
Fatigue (feeling of tiredness): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Laboratory Test Abnormal: 2 people, 16.67%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 50.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 8.33%
Pleural Effusion (water on the lungs): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Breast Cancer: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Detrol and have Bone marrow failure?

- Check whether Bone marrow failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Detrol:

Detrol (28,669 reports)

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow failure:

Bone marrow failure (1,008 drugs)

Browse all the conditions that are associated with Bone marrow failure:

Bone marrow failure (1,438 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Detrol) and Detrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.